Release: Amarantus BioSciences Announces MANF Demonstrates Superiority over...
The following is a news release published October 25 by Amarantus BioSciences discussing positive behavioural efficacy data for MANF, the company's powerful therapeutic protein with neuron-protective...
View ArticleRelease: Amarantus BioSciences Announces Positive Data for MANF in Delivery...
Amarantus BioSciences, Inc. (AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary...
View Article
More Pages to Explore .....
